Analytical Data
-
Gene name
C22orf25
- Application
-
Alternative Names
TANGO2; C22orf25; Transport and Golgi organization Protein 2 homolog
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6ICL3
-
Expression Region
1-276aa
-
AA Sequence
MCIIFFKFDPRPVSKNAYRLILAANRDEFYSRPSKLADFWGNNNEILSGLDMEEGKEGGTWLGISTRGKLAALTNYLQPQLDWQARGRGELVTHFLTTDVDSLSYLKKVSMEGHLYNGFNLIAANLSTAKGDVICYYGNRGEPDPIVLTPGTYGLSNALLETPWRKLCFGKQLFLEAVERSQALPKDVLIASLLDVLNNKEAQLPDPAIEDQGGEYVQPMLSKYAAVCVRCPGYGTRTNTIILVDADGHVTFTERSMMDKDLSHWETRTYEFTLQS
-
Molecular Weight
57.3 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C22orf25, also known as KIAA1462, is a human gene that has garnered attention due to its potential role in various biological processes and its implications in certain diseases. The protein encoded by C22orf25 is thought to be involved in cellular functions such as cell proliferation, differentiation, and apoptosis. Recent studies have indicated that this protein may play a significant role in cancer progression, although the exact mechanisms remain to be fully elucidated. The interest in C22orf25 is heightened by its association with metabolic pathways and immune responses, suggesting that it could serve as a biomarker for disease diagnosis or progression. Additionally, research into the recombinant production of C22orf25 is essential for understanding its structure-function relationship, which could provide insights into its biological activity and interaction with other cellular components. The development of recombinant C22orf25 protein allows for the exploration of its properties in vitro, paving the way for potential therapeutic applications. By integrating biochemical, molecular biology, and genetic approaches, studies focusing on C22orf25 aim to uncover its precise roles in health and disease, making it a promising target for future research in fields such as oncology and metabolic disorders.
